Aprea Therapeutics, Inc. (APRE)
0.9326
+0.03
(+2.79%)
USD |
NASDAQ |
Apr 22, 16:00
0.9326
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Cash from Financing (TTM) : 4.838M for Dec. 31, 2025
Cash from Financing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Modular Medical, Inc. | 22.07M |
| Ernexa Therapeutics, Inc. | 7.209M |
| Recursion Pharmaceuticals, Inc. | 521.53M |
| Tango Therapeutics, Inc. | 222.50M |
| ACADIA Pharmaceuticals, Inc. | 49.88M |